Abiopharma

🔍 Rock Stacey G (Executive)

Company: KRATOS DEFENSE & SECURITY SOLUTIONS, INC. (KTOS)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Sold 3,500 shares of Common Stock at $60.8869 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,397.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Sold 500 shares of Common Stock at $61.992 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,897.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.47 to $61.42 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.63 to $62.34 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F4: Includes 2,013 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 6,991 shares held through Issuer's 401(k) Plan.